EDQM Plans Makeover For Certificates Of Suitability
Regulatory Information On Active Substances To Be Improved
The European Directorate for the Quality of Medicines & HealthCare has launched a project to redesign its “certificates of suitability” to better respond to the needs of drug makers and regulatory authorities in terms of providing relevant information on active substances.
You may also be interested in...
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.